Case Report: Treatment of systemic mastocytosis with sunitinib

F1000Research
Gerhard J MolderingsStefan Brettner

Abstract

Mast cell activation disease typically presents as chronic multisystem polymorbidity of generally inflammatory ± allergic theme.  Presently, treatment of the rare, cytoproliferative variant systemic mastocytosis employs empirically selected therapies to impede mast cell mediator production and action and, when necessary, inhibition of proliferation. Some tyrosine kinase inhibitors (TKIs) have been used successfully in uncommon cases of systemic mastocytosis not bearing that disease's usual imatinib-resistant KIT D816V mutation. Recently, sunitinib, a multi-targeted TKI, had been successful in a case of systemic mast cell activation syndrome. In addition, most allergy is principally a mast cell activation phenomenon, and sunitinib has been shown helpful in controlling a murine model of oral allergy syndrome. Here, we present the first use of sunitinib in systemic mastocytosis.

References

Jun 17, 2006·Cancer·Helga J DroogendijkPaul L A van Daele
Jun 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Srdan VerstovsekHagop Kantarjian
Feb 6, 2009·Leukemia Research·Arturo Vega-RuizSrdan Verstovsek
Sep 9, 2011·Thrombosis and Haemostasis·H SeidelH-J Hertfelder
Jun 16, 2015·European Journal of Haematology·Lawrence B AfrinGerhard J Molderings
Nov 10, 2015·Journal of the National Cancer Institute·Benjamin CarlisleJonathan Kimmelman
Feb 18, 2016·Translational Research : the Journal of Laboratory and Clinical Medicine·Gerhard J Molderings
May 2, 2016·Naunyn-Schmiedeberg's Archives of Pharmacology·Gerhard J MolderingsLawrence B Afrin
Jun 30, 2016·The New England Journal of Medicine·Jason GotlibAndreas Reiter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

European Journal of Haematology
Lawrence B AfrinGerhard J Molderings
The Journal of Allergy and Clinical Immunology
Roberta ZanottiGiovanna De Matteis
Experimental Hematology & Oncology
Lawrence B Afrin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Richard A SpeightSimon Panter
© 2022 Meta ULC. All rights reserved